天然产物 黄酮类 Flavonoids
Irigenin 纯度: 98.91%
Irigenin 是一种先导化合物,通过特异性和选择性地阻断 Extra Domain A (EDA) 域的 C-C 环上 α9β1 和 α4β1 整合素结合位点,介导其抗转移作用。Irigenin 具有抗癌作用。它通过增强胃癌细胞中促凋亡分子的表达来敏化 TRAIL 诱导的凋亡。
Irigenin Chemical Structure
CAS No. : 548-76-5
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥800 | In-stock | |
10 mg | ¥1400 | In-stock | |
20 mg | ¥2300 | In-stock | |
50 mg | 询价 | ||
100 mg | 询价 |
* Please select Quantity before adding items.
Irigenin 相关产品
•相关化合物库:
- Natural Product Library Plus
- Bioactive Compound Library Plus
- Immunology/Inflammation Compound Library
- Natural Product Library
- Anti-Cancer Compound Library
- Phenols Library
- Cytoskeleton Compound Library
- Traditional Chinese Medicine Monomer Library
- Flavonoids Library
- Food-Sourced Compound Library
生物活性 |
Irigenin is a is a lead compound, and mediates its anti-metastatic effect by specifically and selectively blocking α9β1 and α4β1 integrins binding sites on C-C loop of Extra Domain A (EDA). Irigenin shows anti-cancer properties. It sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells[1]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
Irigenin specifically targets α9β1 and α4β1 integrin binding sites on Extra Domain A (EDA) comprising LEU46, PHE47, PRO48, GLU58, LEU59 and GLN60 in its C-C loop. Irigenin binds to the C-C loop of EDA, thereby blocking its interaction with integrins on the cell surface and thus abrogating subsequent Epithelial-Mesenchymal transition[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
360.31 |
||||||||||||||||
Formula |
C18H16O8 |
||||||||||||||||
CAS 号 |
548-76-5 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (277.54 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|